Who we are?

Novel translational approaches

The Victor and George Tetz  Human Microbiology Institute is an independent, not-for-profit research organization that has formed collaborations with a variety of universities, research organizations, hospitals, biotech companies, and other life science organizations. These collaborations yield a multidisciplinary approach and provide a broad range of technical and theoretical expertise. The Human Microbiology Institute performs breakthrough research for the public interest that results in novel translational approaches to medicine.

We utilize our research to identify novel drug targets and to develop innovative technologies, with the ultimate goal of translating these discoveries to human health care.

The tasks

The tasks of the Human Microbiology Institute include researching host-microflora interactions to elucidate the role of the microbiota in different human pathologies and in longevity.

Our studies, performed by world leaders in human microbiome research, and have provided the theoretical basis for the evaluation of novel roles of the human microbiota in the development of numerous diseases, as well as in aging and longevity. Based on these theories, we have performed next-generation experimental microbiome research, which has yielded novel information regarding the role of the microbiota in human health and new paradigms for the cross-talk between microbes and humans.

Furthermore, to ensure the continued development of these innovations, we at the Human Microbiology Institute aim for excellence, not only in research, but also in teaching and molding young scientists to be leaders at the cutting edge of tomorrow’s research.

Human Microbiology Institute:
  • Breakthrough science. Our breakthrough science is at the forefront of today’s knowledge, enabling us to develop novel concepts and drugs for tomorrow’s use.
  • Fast track. Rapid application of our ideas and innovations
  • We know – you know. We know how to accelerate the understanding and treatment of human diseases and try to make our knowledge open and available to the scientific community.